Michael S. Ryan Inc’s AbbVie ABBV Stock Holding History

Michael S. Ryan Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.04M	Buy	3,989 +135	+4%	+$34.6K	0.53%	25
2026 Q2	$970K	Buy	3,854 +4	+0.1%	+$861	0.48%	26
2026 Q1	$837K	Buy	3,850 +48	+1%	+$10.6K	0.49%	24
2025 Q4	$869K	Sell	3,802 -7	-0.2%	-$1.6K	0.5%	25
2025 Q3	$882K	Hold	3,809	–	–	0.53%	24
2025 Q2	$707K	Buy	3,809 +174	+5%	+$32.3K	0.45%	25
2025 Q1	$762K	Hold	3,635	–	–	0.53%	23
2024 Q4	$646K	Buy	3,635 +75	+2%	+$13.8K	0.44%	24
2024 Q3	$703K	Sell	3,560 -177	-5%	-$33K	0.49%	22
2024 Q2	$641K	Sell	3,737 -357	-9%	-$59.1K	0.49%	24
2024 Q1	$746K	Sell	4,094 -108	-3%	-$18.6K	0.59%	20
2023 Q4	$651K	Hold	4,202	–	–	0.54%	23
2023 Q3	$593K	Hold	4,202	–	–	0.57%	24
2023 Q2	$567K	Buy	+4,202	New	+$616K	0.52%	27

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Michael S. Ryan Inc's ABBV Position: Q3 2026 in Review

Michael S. Ryan Inc increased its AbbVie (ABBV) stake by 3.5% in Q3 2026, buying an estimated $34.6K and bringing the position to 3,989 shares worth $1.04M. The position accounts for 0.53% of the portfolio, ranked #25.

Michael S. Ryan Inc first reported a position in ABBV in Q2 2023 and has held it in 14 quarters since. 1,911 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Michael S. Ryan Inc held 3,989 shares of AbbVie worth $1.04M as of Q3 2026.
Michael S. Ryan Inc bought 135 AbbVie shares in Q3 2026, an estimated $34.6K.
AbbVie made up 0.53% of Michael S. Ryan Inc's portfolio in Q3 2026, its #25 holding.
Michael S. Ryan Inc first reported a position in AbbVie in Q2 2023 and has held it in 14 quarters since.
1,911 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Michael S. Ryan Inc's 13F filing for Q3 2026, filed 1 Oct 2026.